Profile
Andy Rittenberg is currently Chief Legal Officer at Coherus Oncology, Inc. from 2024 to present.
Formerly, Mr. Rittenberg was Chief Compliance Officer & Senior VP-Legal at Gilead Sciences, Inc. from 2006 to 2023, and Attorney at Covington & Burling LLP from 1999 to 2006.
Education includes graduate studies at The University of Chicago and undergraduate studies at Yale University.
Andy Rittenberg active positions
| Companies | Position | Start |
|---|---|---|
| COHERUS ONCOLOGY, INC. | General Counsel | 01/01/2024 |
Former positions of Andy Rittenberg
| Companies | Position | End |
|---|---|---|
| GILEAD SCIENCES, INC. | Compliance Officer | 01/08/2023 |
Covington & Burling LLP
Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Corporate Officer/Principal | 01/04/2006 |
Training of Andy Rittenberg
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Gilead Sciences, Inc.
Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Covington & Burling LLP
Covington & Burling LLP Miscellaneous Commercial ServicesCommercial Services Provides legal services | Commercial Services |
The University of Chicago
The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Coherus BioSciences, Inc.
Coherus BioSciences, Inc. Pharmaceuticals: MajorHealth Technology Operates as a commercial-stage biopharmaceutical company that engages in research, development and commercialization of immunotherapies to treat cancer | Health Technology |
- Stock Market
- Insiders
- Andy Rittenberg
















